1. Home
  2. GNSS vs MIST Comparison

GNSS vs MIST Comparison

Compare GNSS & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNSS
  • MIST
  • Stock Information
  • Founded
  • GNSS 1992
  • MIST 2003
  • Country
  • GNSS United States
  • MIST Canada
  • Employees
  • GNSS N/A
  • MIST N/A
  • Industry
  • GNSS Consumer Electronics/Appliances
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNSS Consumer Staples
  • MIST Health Care
  • Exchange
  • GNSS Nasdaq
  • MIST Nasdaq
  • Market Cap
  • GNSS 78.1M
  • MIST 89.8M
  • IPO Year
  • GNSS N/A
  • MIST N/A
  • Fundamental
  • Price
  • GNSS $1.90
  • MIST $2.33
  • Analyst Decision
  • GNSS Strong Buy
  • MIST Strong Buy
  • Analyst Count
  • GNSS 3
  • MIST 2
  • Target Price
  • GNSS $5.33
  • MIST $7.50
  • AVG Volume (30 Days)
  • GNSS 130.7K
  • MIST 640.4K
  • Earning Date
  • GNSS 08-05-2025
  • MIST 08-07-2025
  • Dividend Yield
  • GNSS N/A
  • MIST N/A
  • EPS Growth
  • GNSS N/A
  • MIST N/A
  • EPS
  • GNSS N/A
  • MIST N/A
  • Revenue
  • GNSS $27,780,000.00
  • MIST N/A
  • Revenue This Year
  • GNSS $91.14
  • MIST N/A
  • Revenue Next Year
  • GNSS $75.44
  • MIST N/A
  • P/E Ratio
  • GNSS N/A
  • MIST N/A
  • Revenue Growth
  • GNSS N/A
  • MIST N/A
  • 52 Week Low
  • GNSS $1.46
  • MIST $0.63
  • 52 Week High
  • GNSS $4.04
  • MIST $2.75
  • Technical
  • Relative Strength Index (RSI)
  • GNSS 65.63
  • MIST 78.63
  • Support Level
  • GNSS $1.48
  • MIST $1.86
  • Resistance Level
  • GNSS $1.85
  • MIST $1.97
  • Average True Range (ATR)
  • GNSS 0.09
  • MIST 0.12
  • MACD
  • GNSS 0.04
  • MIST 0.04
  • Stochastic Oscillator
  • GNSS 100.00
  • MIST 97.12

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: